Valuation: Amgen Inc.

Market Cap 24TCr 7,75700Cr 20TCr 19TCr 17TCr 33TCr 22,72500Cr 33TCr 2,24900Cr 88TCr 11,41600Cr 89TCr 87TCr 37,75900Cr P/E 2026 *
27.8x
P/E 2027 * 24.9x
Enterprise Value 28TCr 9,11100Cr 24TCr 22TCr 20TCr 38TCr 26,69500Cr 39TCr 2,64200Cr 1,03000Cr 13,41000Cr 1,04800Cr 1,02500Cr 44,35500Cr EV / Sales 2026 *
7.17x
EV / Sales 2027 * 6.8x
Free-Float
99.77%
Yield 2026 *
2.3%
Yield 2027 * 2.43%
1 day-3.85%
1 week+0.57%
Current month+8.70%
1 month+13.64%
3 months+28.68%
6 months+19.05%
1 week 3.36
Extreme 3.36
3.66
1 month 3.04
Extreme 3.04
3.66
Current year 2.6
Extreme 2.6
3.66
1 year 2.6
Extreme 2.6
3.66
3 years 2.6
Extreme 2.6
3.66
5 years 2.6
Extreme 2.6
3.66
10 years 2.6
Extreme 2.6
3.66
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Director of Finance/CFO 67 01/01/2020
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
-3.85%+0.57% - - 24TCr
+0.88%+6.38%+76.86%+128.23% 1,11900Cr
+1.07%+3.80%+51.03%+61.48% 65TCr
+1.20%+6.21%+26.47%+76.45% 47TCr
+1.02%+5.77%+43.09%+47.70% 37TCr
+0.85%+4.07%+23.88%+41.58% 30TCr
+1.26%+6.81%+1.59%+14.67% 26TCr
+1.88%+5.81%+48.54%+68.52% 24TCr
+1.59%+2.09%-15.52%-52.29% 21TCr
+1.87%+5.61%+25.81%+92.42% 18TCr
Average +0.78%+4.10%+31.31%+53.20% 42.22TCr
Weighted average by Cap. +0.84%+4.47%+44.31%+72.55%

Financials

2026 *2027 *
Net sales 3.89TCr 1,27200Cr 3.34TCr 3.12TCr 2.86TCr 5.36TCr 3,72600Cr 5.43TCr 37TCr 14TCr 1,87200Cr 15TCr 14TCr 6,19000Cr 4.02TCr 1,31300Cr 3.44TCr 3.22TCr 2.95TCr 5.53TCr 3,84600Cr 5.61TCr 38TCr 15TCr 1,93200Cr 15TCr 15TCr 6,39000Cr
Net income 859.76Cr 28TCr 736.47Cr 689.1Cr 630.79Cr 1.18TCr 82TCr 1.2TCr 8.14TCr 3.17TCr 41TCr 3.23TCr 3.16TCr 1,36700Cr 939.37Cr 31TCr 804.66Cr 752.9Cr 689.2Cr 1.29TCr 90TCr 1.31TCr 8.9TCr 3.47TCr 45TCr 3.53TCr 3.45TCr 1,49300Cr
Net Debt 4.15TCr 1,35500Cr 3.55TCr 3.33TCr 3.04TCr 5.71TCr 3,96900Cr 5.79TCr 39TCr 15TCr 1,99400Cr 16TCr 15TCr 6,59500Cr 3.58TCr 1,17000Cr 3.07TCr 2.87TCr 2.63TCr 4.93TCr 3,42800Cr 5TCr 34TCr 13TCr 1,72200Cr 13TCr 13TCr 5,69600Cr
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
21/26/21 THB 3.500 -3.85% 20,009
20/26/20 THB 3.640 +4.00% 21,628
19/26/19 THB 3.500 0.00% 21,902
18/26/18 THB 3.500 +3.55% 4,574
17/26/17 THB 3.380 -2.87% 2,479
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
439.33USD
Average target price
388.48USD
Spread / Average Target
-11.57%

Quarterly revenue - Rate of surprise